Investment underscores Aizon’s leadership position in AI-enhanced pharmaceutical manufacturing and will accelerate growth and launch of next-generation eBR
Aizon, an Artificial Intelligence (AI) SaaS provider that transforms pharmaceutical manufacturing operations, announced that it has closed $20 million in Series C funding led by NewVale Capital, a growth equity fund that...
ZEPHYRx® and NIOX® announced they have partnered to integrate FeNO by NIOX® into the ZEPHYRx Respiratory Cloud Platform to advance clinical research by offering one source of truth for multiple respiratory endpoints.
ZEPHYRx, a health information technology innovator, has quickly become an industry leader in respiratory monitoring solutions for hybrid clinical research. In...
o integrate diverse data in decentralized clinical trials and offer enhanced multi-site, multi-lingual integrations
ObvioHealth, a global digital clinical trials company, and Oracle Life Sciences are expanding their partnership globally following the results of a year-long, successful effort launching trials in Asia Pacific. The collaboration will enable the efficient capture, integration, and analysis...
Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced positive preclinical data of its lung fibrosis candidate. This drug operates through a novel mRNA biology mechanism of action, opening new avenues for treating Idiopathic Pulmonary Fibrosis (IPF) patients.
Utilizing its mRNA Lightning™ Platform, Anima has successfully identified a...
Standard BioTools Inc., driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – announced a collaboration agreement with Navignostics AG for development of clinical research applications and service offerings using the Hyperion XTi™ Imaging System.
This collaboration is pivotal in the fight against cancer, emphasizing...
Multicenter EXCYTE-2 Study to Evaluate the Precision Medicine Platform in Patients With Acute Myeloid Leukemia
Exscientia plc announced the launch of EXCYTE-2, an observational clinical trial in acute myeloid leukemia (AML), known as. This study aims to examine the relationship between ex vivo drug response (EVDR), measured on individual cells in...
VantAI, a leader in generative AI and drug discovery, announced the appointment of Jae Won Kim as Chief Operating Officer (COO) and Chief Financial Officer (CFO). Ms. Kim is an experienced finance, corporate development, and operations executive with a strong track record, especially in drug discovery and the induced...
Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, has announced that Gary Frazier has been selected as Chief Growth Officer for the firm. Frazier brings extensive experience in several key aspects of healthcare to the position.
Frazier is the founder and CEO of two...
In recent years, the integration of artificial intelligence (AI) has sparked a transformative shift in the way we approach healthcare, disease diagnosis, and drug discovery. With the ability to process vast amounts of data and identify complex patterns, AI has become an indispensable tool in the pursuit of innovative...
Novel solution distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample
biomodal, an omics-based life sciences technology and analytics company, announced it is delivering the 6-base genome to customers with the launch of duet multiomics solution evoC (duet...
